Skip Navigation Links
Listar:
  CódigoNome do ExameSinonimoMetodologiaVolumeMaterialRecipienteTransportePrazoRotinaAlteração recente
Visualizar alteraçõesCAXGCAXUMBA - ANTICORPO IgGPAROTIDITE, PARAMIXOVIRUSENZIMAIMUNOENSAIO3 mLSOROGEL SEPARADORRefrigerado (2 a 8 °C)5 dias uteisSeg,Ter,Qua,Qui,SexSIM
Visualizar alteraçõesCAXMCAXUMBA - ANTICORPO IgMPAROTIDITE, PARAMIXOVIRUSENZIMAIMUNOENSAIO3 mLSOROGEL SEPARADORRefrigerado (2 a 8 °C)5 dias uteisSeg,Ter,Qua,Qui,SexSIM
Visualizar alteraçõesANGEOENZIMA CONVERSORA ANGIOTENSINA - AUTORIZAÇÃO DIRETORIA CEACECA, ACE, ANGIOTENSINA CONVERTASE, SARCOIDOSEESPECTROFOTOMETRIA CINÉTICA3 mLSOROGEL SEPARADORRefrigerado (2 a 8 °C)5 dias uteisQuiSIM
Visualizar alteraçõesHCVPCHEPATITE C - PCR QUANTITATIVOCARGA VIRAL DO HCVSEM4 mLPLASMA EDTA CONGELADOTUBO ROXO EDTA GELCongelado7 dias uteisSeg,Ter,Qua,Qui,SexSIM
Visualizar alteraçõesDELTAHEPATITE DHEPATITE DELTAENZIMAIMUNOENSAIO3 mLSORO CONGELADOGEL SEPARADORRefrigerado (2 a 8 °C)15 dias uteisTerSIM
Visualizar alteraçõesHPVPCPAPILOMAVÍRUS HUMANO - CARGA VIRAL E GENOTIPAGEMHPVSEM0 mLSEMDIVERSOSRefrigerado (2 a 8 °C)8 dias uteisSeg,Ter,Qua,Qui,SexSIM
Visualizar alteraçõesSACCHSACCHAROMYCES CEREVISIAE - ANTI - AUTORIZAÇÃO DIRETORIAASCA IgG E IgA, DOENÇA DE CROHN, ENZIMAIMUNOENSAIO3 mLSOROGEL SEPARADORRefrigerado (2 a 8 °C)6 dias uteisQuiSIM
Bibliografia :
1. US Department of Labor, Occupational Safety and Health Administration. 29 CFR Part 1910.1030. Occupational Exposure to Bloodborne Pathogens.
2. US Department of Health and Human Services. Biosafety in Microbiological and Biomedical Laboratories. 5th ed. Washington, DC: US Government Printing Office; January 2007.
3. World Health Organization. Laboratory Biosafety Manual. Geneva: World Health Organization; 2004.
4. Sewell DL, Bove KE, Callihan DR, et al. Protection of Laboratory Workers from Occupationally Acquired Infections; Approved Guideline- Third Edition (M29-A3). Wayne, PA: Clinical and Laboratory Standards Institute, 2005.
5. Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry, 2nd ed. Philadelphia, PA: WB Saunders; 1994:959-60.
6. Tietz NW, editor. Clinical Guide to Laboratory Tests, 3rd ed. Philadelphia, PA: WB Saunders; 1995:268-72.
7. Kaplan LA, Pesce AJ, editors. Clinical Chemistry Theory, Analysis, and Correlation, 3rd ed. St Louis, MO: CV Mosby; 1996:635.
8. Guder WG, Narayanan S, Wisser H, et al. List of analytes-preanalytical variables. Annex In: Samples: From the Patient to the Laboratory. Darmstadt, Germany: GIT Verlag; 1996:Annex 16-7, 38-9, 44-5.
9. US Pharmacopeial Convention, Inc. General notices. In: US Pharmacopeia National Formulary, 1995 ed (USP 23/NF 18). Rockville, MD: The US Pharmacopeial Convention, Inc; 1994:11. 10. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2007;30(1):42-7.
11. Sacks DB, Bruns DE, Goldstein DE, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48(3):436-72.
12. Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry, 2nd ed. Philadelphia, PA: WB Saunders; 1994:2190.
13. Young DS. Effects of Drugs on Clinical Laboratory Tests, 4th ed. Washington, DC: AACC Press; 1995:3-274-3-294.
14. Kennedy JW, Carey RN, Coolen RB, et al. Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline (EP5- A). Wayne, PA: The National Committee for Clinical Laboratory Standards, 1999.
15. Krouwer JS, Tholen DW, Garber CC, et al. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline-Second Edition (EP9-A2). Wayne, PA: The National Committee for Clinical Laboratory Standards, 2002.
16.John Bernard Henry,M.D Diagnósticos Clínicos e Tratamento por Métodos Laboratoriais.
17.Sociedade Brasileira de Patologia Clínica / Medicina Laboatorial. (2ª edição).